NCT00312338View on ClinicalTrials.gov

Topical Treatment of Bacterial Conjunctivitis and Its Effect on Microbial Flora

PHASE4CompletedINTERVENTIONAL
Enrollment

137

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

June 30, 2007

Study Completion Date

June 30, 2007

Conditions
Bacterial Conjunctivitis
Interventions
DRUG

VIGAMOX

1 drop of VIGAMOX® ophthalmic solution 0.5% in both eyes TID for 7 days

Trial Locations (1)

76134

Multiple Locations, Fort Worth

Sponsors

Lead Sponsor

Alcon Research
All Listed Sponsors
collaborator

Tufts University

OTHER

lead

Alcon Research

INDUSTRY

NCT00312338 - Topical Treatment of Bacterial Conjunctivitis and Its Effect on Microbial Flora | Biotech Hunter | Biotech Hunter